$PETV PetVivo to Exhibit at the American Associati
Post# of 151
(Total Views: 25)
Posted On: 12/02/2025 10:45:10 AM
$PETV PetVivo to Exhibit at the American Association of Equine Practitioners Convention on December 6-10, 2025
https://www.einpresswire.com/article/87164452...-6-10-2025
PetVivo Holdings, Inc. (OTCQX
ETV, PETVW)
MINNEAPOLIS, MN, UNITED STATES, December 1, 2025 /EINPresswire.com/ -- PetVivo Animal Health, Inc., in cooperation with its parent PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and affiliate PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, will exhibit at the American Association of Equine Practitioners (“AAEP”) convention to be held December 6th to December 10th, 2025 at the Colorado Convention Center, Exhibit Halls B, C and D, in Denver, Colorado.
PetVivo will exhibit its lead products, Spryng® with OsteoCushion® Technology and PrecisePRP™. Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles. The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue. Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.
PrecisePRP is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. PrecisePRP is a leucoreduced, allogeneic, pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration in dogs and horses. Unlike any PRP mechanical kits currently on the market, PrecisePRP™ does not require a blood draw or centrifugation making it a truly off-the-shelf product that is easy and convenient. Perhaps more important is the uniformity and consistency that PrecisePRP® guarantees. Each vial of PrecisePRP® contains a consistent dose of 4 billion platelets per vial at a concentration of 500,000 platelets per microliter and is leucoreduced with less than 1500 white blood cells per microliter.
“AAEP brings together the leading experts in equine health, and we are proud to participate again this year. Both Spryng with OsteoCushion Technology and PrecisePRP continue to demonstrate meaningful clinical value for horses suffering from joint and soft-tissue challenges. Our commitment remains focused on supporting veterinarians with innovative solutions that improve mobility, performance, and overall quality of life for their equine patients.”
Visitors to the AAEP Convention can see the Spryng exhibit at Booth #2406 on December 7, 2025, 10:00 a.m. to 6:00 p.m., December 8, 2025, 10:00 a.m. to 6:00 p.m. and December 9, 10:00 a.m. to 4:00 p.m.
For more information about Spryng and PrecisePRP, please contact info1@petvivo.com or visit petvivo.com, petvivoanimalhealth.com and sprynghealth.com.
https://www.einpresswire.com/article/87164452...-6-10-2025
PetVivo Holdings, Inc. (OTCQX
ETV, PETVW) MINNEAPOLIS, MN, UNITED STATES, December 1, 2025 /EINPresswire.com/ -- PetVivo Animal Health, Inc., in cooperation with its parent PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and affiliate PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, will exhibit at the American Association of Equine Practitioners (“AAEP”) convention to be held December 6th to December 10th, 2025 at the Colorado Convention Center, Exhibit Halls B, C and D, in Denver, Colorado.
PetVivo will exhibit its lead products, Spryng® with OsteoCushion® Technology and PrecisePRP™. Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles. The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue. Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.
PrecisePRP is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. PrecisePRP is a leucoreduced, allogeneic, pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration in dogs and horses. Unlike any PRP mechanical kits currently on the market, PrecisePRP™ does not require a blood draw or centrifugation making it a truly off-the-shelf product that is easy and convenient. Perhaps more important is the uniformity and consistency that PrecisePRP® guarantees. Each vial of PrecisePRP® contains a consistent dose of 4 billion platelets per vial at a concentration of 500,000 platelets per microliter and is leucoreduced with less than 1500 white blood cells per microliter.
“AAEP brings together the leading experts in equine health, and we are proud to participate again this year. Both Spryng with OsteoCushion Technology and PrecisePRP continue to demonstrate meaningful clinical value for horses suffering from joint and soft-tissue challenges. Our commitment remains focused on supporting veterinarians with innovative solutions that improve mobility, performance, and overall quality of life for their equine patients.”
Visitors to the AAEP Convention can see the Spryng exhibit at Booth #2406 on December 7, 2025, 10:00 a.m. to 6:00 p.m., December 8, 2025, 10:00 a.m. to 6:00 p.m. and December 9, 10:00 a.m. to 4:00 p.m.
For more information about Spryng and PrecisePRP, please contact info1@petvivo.com or visit petvivo.com, petvivoanimalhealth.com and sprynghealth.com.
(0)
(0)